CJC-1295 no DAC + Ipamorelin | Growth Hormone Synergy Bundle

Growth Hormone Synergy Bundle – CJC-1295 (no DAC) + Ipamorelin

The Growth Hormone Synergy Bundle combines two well-characterized research peptides — CJC-1295 (no DAC), a synthetic growth hormone–releasing hormone (GHRH) analogue, and Ipamorelin, a selective growth hormone secretagogue (GHS). This pairing is widely studied for its dual modulation of the growth hormone axis through complementary receptor pathways, providing researchers with a model to explore complex endocrine signaling mechanisms.

Key Features

• CJC-1295 (no DAC): A GHRH analogue studied for its role in promoting pulsatile growth hormone (GH) release in controlled experimental models.
• Ipamorelin: A selective ghrelin receptor agonist evaluated for its specificity, reduced off-target signaling, and GH-stimulating potential.
• Synergistic Design: Commonly examined together in research due to their complementary effects on GH regulation pathways.
• High Purity: Both peptides are lyophilized under controlled conditions and manufactured to stringent quality specifications.

Product Specifications

• Contents: 10mg CJC-1295 (no DAC) + 10mg Ipamorelin (lyophilized vials)
• Form: White to off-white lyophilized powder
• Storage: Store at 2–8°C, protected from light and moisture. For long-term storage, below -20°C is recommended.
• Solubility: Soluble in sterile or bacteriostatic water for laboratory use

Scientific Background

CJC-1295 (no DAC) and Ipamorelin are often co-administered in laboratory studies to evaluate synergistic stimulation of growth hormone secretion. CJC-1295 (no DAC) acts through the GHRH receptor to enhance the amplitude and frequency of GH pulses, while Ipamorelin interacts with the ghrelin (GHS-R) receptor, stimulating GH release through a distinct signaling pathway. This dual activation model allows researchers to study potential additive or synergistic responses within the growth hormone axis.

Technical Information

CJC-1295 (no DAC)

• Synonyms: CJC-1295 without DAC, Modified GRF (1–29)
• CAS Number: 863288-34-0
• Molecular Formula: C152H252N44O42
• Molecular Weight: 3367.96 g/mol
• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Gln-Lys-Leu-Leu-Gln-Asp-Ile-Met-NH₂
• Form: Lyophilized powder
• Purity: ≥99% (HPLC verified)

Ipamorelin

• Synonyms: Ipamorelin Acetate
• CAS Number: 170851-70-4
• Molecular Formula: C38H49N9O5
• Molecular Weight: 711.85 g/mol
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Form: Lyophilized powder
• Purity: ≥99% (HPLC verified)

Why Researchers Choose This Bundle

The Growth Hormone Synergy Bundle enables laboratories to investigate overlapping pathways in growth hormone regulation through a dual-receptor model. Researchers value this combination for its precision, reliability, and the ability to explore peptide-driven modulation of the GH axis under controlled experimental conditions.

References

• Bowers CY et al. “Ipamorelin: a selective growth hormone secretagogue.” Endocrinology, 1996.
• Teichman SL et al. “CJC-1295, a long-acting GHRH analog, increases GH and IGF-I levels in healthy adults.” Journal of Clinical Endocrinology & Metabolism, 2006.
• PubChem Database – Ipamorelin (CID 25087130) , U.S. National Library of Medicine.